Chairman
Professor Silviu Itescu, MBBS (Hons), FRACP, FACP, FACR

Professor Itescu is the founder of Mesoblast Limited and Angioblast Systems, Inc. Most recently Director of Transplantation Immunology at New York's Columbia University Medical Center, Professor Itescu has established an outstanding international reputation in the fields of stem cell biology, autoimmune diseases, organ transplantation and heart failure. His experiences range from laboratory research to new drug development and clinical evaluation. Professor Itescu recently pioneered novel approaches to the use of adult stem cells for the treatment of heart disease and is leading international collaborative trials in this area. Professor Itescu was an advisor on cell therapy for cardiovascular diseases to both the US President's Council on Bioethics and the US FDA Biological Response Modifiers Advisory Committee (BRMAC). He has consulted for many international pharmaceutical companies and has been an advisor to biotechnology and health care investor groups.

Member
Professor Richard E Gilbert, MBBS, PhD, FRACP

Professor Gilbert is Professor of Medicine at the University of Melbourne where he directs a large research program exploring new therapeutic strategies for the treatment of cardiovascular and kidney disease. Professor Gilbert is an international authority on the complications of diabetes, particularly vascular, eye and kidney diseases. In 2004, he was awarded the prestigious Eric Susman Medal from the Royal Australasian College of Physicians for outstanding contributions in diabetes research. Professor Gilbert consults to many global pharmaceutical and biotechnology companies on drug discovery, preclinical testing and clinical trials.

Member
Professor Robert M Graham, FAA, MBBS (Hons), MD, FRACP, FACP, FAHA

Professor Graham is the Des Renford Professor of Medicine, University of NSW; Executive Director, Victor Chang Cardiac Research Institute, Sydney; and Professor (adjunct) of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, USA. His research has focused on molecular cardiology, with emphasis on circulatory control mechanisms, receptor signalling and cardiac hypertrophy. Professor Graham is the author of more than 200 peer-reviewed papers, is a Fellow of the Australian Academy of Science and a member of the American Association for Clinical Research, the American Society of Clinical Investigation, the American Heart Association, and the National Heart Foundation of Australia (NSW Division). He has been a consultant to many pharmaceutical and biotechnology companies. Currently, he is Chairman, Scientific Committee, Cardiac Society of Australia and New Zealand; Member NSW Ministerial Advisory council on Medical and Health Research and Board Member, EngenelC Ltd, MirACL Therapeutics Pty Ltd and the Lowy Medical Foundation.

Member
Professor Stephen Graves, MBBS, D. Phil FRACS, FA, Orth A

Professor Graves was the inaugural Professor of Orthopaedics at the University of Melbourne and Director of Orthopaedics at the Royal Melbourne Hospital, where he remains Director of Orthopaedic Research. He is currently Director of Musculoskeletal Research at Epworth Hospital and Flinders Medical Centre; Director of the Australian Orthopaedic Association National Joint Replacement Registry; Chairman of the Australian Orthopaedic Association Bone and Tissue Banking Committee and member of the Commonwealth Health Department Hip and Knee Prostheses Clinical Advisory Groups. He is a member of the Therapeutic Goods Administration (TGA) Medical Device Evaluation Committee (MDEC), Expert Advisory Group on Cell & Tissue Based Therapies and subcommittee on Device Tracking.

Member
Professor Henry Krum, MBBS, PhD, FRACP

Professor Krum is Chair of Medical Therapeutics at Monash University, Melbourne, and is an Adjunct Faculty member of Columbia University, New York. He is also Director of the NHMRC Centre of Clinical Research Excellence in Therapeutics at Monash University. Professor Krum is currently a member of the Pzizer Global Heart Failure Advisory Boards, has previously served on Glaxo Smith Kline and Roche Global Advisory Boards, and is Chairman of the Working Group on Heart Failure of the Cardiac Society of Australia and New Zealand. Professor Krum has been Principal Investigator, Chairman and Advisory Board Member for numerous international and national trials in cardiovascular therapeutics, and has consulted for many pharmaceutical companies, investment banks, and venture capital firms.

Member
Professor Joseph Lane, AB,MD

Professor Joseph Lane is Professor of Orthopaedic Surgery and Assistant Dean at Weill Medical College of Cornell University in New York. Professor Lane's clinical expertise includes spine and hip trauma, spinal surgery, osteoporosis-related fractures, and non-union fractures. At the Hospital for Special Surgery in New York, he is Medical Director of the Osteoporosis Center, Chief of the Metabolic Bone Disease Service, and Associate Director of the Trauma Service. Professor Lane has served as Chairman for the American Academy of Orthopaedic Surgeons (AAOS) Oversight Panel on Women's Health, and was also a member of the AAOS Council on Research. He was President of the Orthopaedic Research Society and Musculoskeletal Tumor Society. He serves as a reviewer of several journals including Journal of Bone and Joint Surgery, Journal of Orthopaedic Trauma, Clinical Orthopaedics and Related Research, and Spine. Professor Lane has published over 300 articles and chapters and served as member and chairman of several of the United States National Health Institute (NIH) study sections.

About us
Organisation
Executive management
Scientific Advisory Board
Corporate Governance